Canada's NHP regulations are shifting. ๐ฟ
On June 30 at 1:00 PM ET, QSS is hosting a live webinar covering NHP classification, licensing pathways, common challenges, and what is changing right now.
๐: na3.hubs.ly/y0v_k40#NHP#HealthCanada#RegulatoryAffairs#Webinar
โณ Great day at the John Holtmann Memorial Golf Tournament, presented by CHFA. Always good to connect with industry colleagues in person.
๐ na3.hubs.ly/y0vP120#CHFA#NaturalHealth
Today at 1:00 PM ET. ๐
Our GRAS vs NDI webinar is live today. Still time to join QSS Senior Regulatory Specialist Bryana Hallam as she breaks down both U.S. ingredient pathways. ๐ฌ
Join here: na3.hubs.ly/y0sk070 ๐
#FDACompliance#RegulatoryAffairs
๐งช GRAS status for a botanical extract doesn't transfer from the parent plant. Each extract needs its own dossier. Here's what the process actually involves.
๐ na3.hubs.ly/y0vFxH0#GRAS#FDA
One week until our GRAS vs NDI webinar. ๐
June 9 at 1:00 PM ET. QSS Senior Regulatory Specialist Bryana Hallam breaks down both U.S. ingredient pathways and how to choose the right one. ๐ฌ
Still open: na3.hubs.ly/y0sjYr0 ๐
#FDACompliance#RegulatoryAffairs
๐งช FDA finalized its food chemical safety assessment program on May 12, 2026. BHT and ADA are first up for review. RFIs open until July 13. GRAS substances are within scope.
๐ na3.hubs.ly/y0v1q50#FDA#FoodSafety
๐ FDA updated its OMUFA arrears list on May 11, 2026. FY 2026 facility fees due June 1. Non-payment = public listing misbranding of OTC products.
๐ na3.hubs.ly/y0v1k20#FDA#OTCDrugs
๐ฉบ FDA proposes 510(k) exemptions for certain Class II clinical toxicology test system devices. Comment period closes June 30, 2026.
๐ na3.hubs.ly/y0v0T10#MedicalDevices#FDA
Choosing the wrong regulatory pathway for your ingredient can mean legal exposure or starting over. Getting it right from the start protects your timeline and your U.S. market entry. Join us June 9 at 1:00 PM ET: na3.hubs.ly/y0sjZl0 ๐
#FDACompliance#RegulatoryAffairs
In Ottawa this week for the CHFA Ottawa Regulatory Forum. Good conversations with NNHPD and Health Canada on where the NHP space is heading. A lot in motion right now. ๐ #CHFA#RegulatoryAffairs
The FDA is now conducting one-day inspectional assessments across supplements, food, biologics, and medical devices. ๐จ Shorter visits, same authority to escalate. Is your facility ready?
๐ na3.hubs.ly/y0tkpN0#FDA#FDAInspections
Health Canada is amending NHP labelling requirements before 2028. ๐ฟ Draft regs targeted for spring 2027. New transition period coming. The June 2028 deadline still stands. ๐ Now is the time to review, not wait.
๐ na3.hubs.ly/y0s-7n0#HealthCanada#NHP
TBT to Vitafoods Europe ๐ โ great connecting with Kevin McIsaac from Inner Armour Sports Nutrition, Lynda Doyle from GRA Nutra, and the team at Enzyme Bioscience. #VitafoodsEurope#Nutraceuticals
GRAS or NDI? The pathway you choose shapes your entire U.S. market entry timeline.
Join QSS's Bryana Hallam on June 9 at 1:00 PM ET to break down both options and how to choose the right one. ๐ฌ
Reserve your spot: na3.hubs.ly/y0sj_Y0 ๐
#FDACompliance#RegulatoryAffairs
Whole ingredient GRAS status does not automatically extend to an extract. ๐งช The FDA treats them as different substances, and each requires its own safety determination.
๐ na3.hubs.ly/y0sxJy0#GRAS#FDA
Andrew's Vitafoods Europe 2025 wrap is live. ๐ฌ Real conversations, real regulatory questions, and we'll be at IFT FIRST in Chicago this July. Connect with us ahead of the show: na3.hubs.ly/y0ssX20 ๐ค
#IFT2026#Vitafoods
We're at Vitafoods Europe in Barcelona this week. ๐ Come find us on the floor if you want to talk North American regulatory strategy for supplements, ingredients, or functional foods. ๐ค
๐ bit.ly/41OWmhM#Vitafoods2026#RegulatoryAffairs
Health Canada just released its first prebiotic monograph. ๐ฟ Eight ingredients. Specific dosage ranges. Mandatory label requirements. What you need to know before your next NHP submission. ๐
๐ na3.hubs.ly/y0s3r10#HealthCanada#NHP